| scholarly article | Q13442814 |
| P50 | author | Aleksandra Simiczyjew | Q59694016 |
| Dorota Nowak | Q59694021 | ||
| Ewelina Dratkiewicz | Q59696188 | ||
| Marleen Van Troys | Q61116293 | ||
| Christophe Ampe | Q87750495 | ||
| P2093 | author name string | Ilona Styczeń | |
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| EGFR/Met association regulates EGFR TKI resistance in breast cancer | Q24338635 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology | Q26849519 | ||
| Analysis of Invasion Dynamics of Matrix-Embedded Cells in a Multisample Format. | Q52360252 | ||
| Epidermal growth factor receptor expression as a prognostic indicator in breast cancer | Q67902986 | ||
| MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling | Q27851406 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Assembly and biological role of podosomes and invadopodia | Q28272503 | ||
| Triple-Negative Breast Cancer | Q29391607 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies | Q29615606 | ||
| CellMissy: a tool for management, storage and analysis of cell migration data produced in wound healing-like assays | Q30659486 | ||
| Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. | Q34032640 | ||
| Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer | Q34135362 | ||
| Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
| Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. | Q34307548 | ||
| cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer | Q34438708 | ||
| Drug development of MET inhibitors: targeting oncogene addiction and expedience | Q34782774 | ||
| Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6 | Q35625440 | ||
| MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition | Q36265149 | ||
| Signaling networks assembled by oncogenic EGFR and c-Met | Q36392991 | ||
| Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells | Q37141943 | ||
| cMET and phospho-cMET protein levels in breast cancers and survival outcomes | Q37290053 | ||
| Cell migration and invasion assays as tools for drug discovery | Q37378102 | ||
| Crosstalk in Met receptor oncogenesis | Q37598460 | ||
| Understanding breast cancer - The long and winding road | Q37634220 | ||
| Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers. | Q37688459 | ||
| Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? | Q37694203 | ||
| MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer. | Q39016645 | ||
| The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix | Q39350905 | ||
| Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function | Q40304153 | ||
| Mechanism of action of the multikinase inhibitor Foretinib. | Q44633972 | ||
| Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity | Q46328432 | ||
| EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations | Q46513909 | ||
| Active invadopodia of mesenchymally migrating cancer cells contain both β and γ cytoplasmic actin isoforms | Q49099425 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| cancer research | Q3421914 | ||
| P304 | page(s) | 335 | |
| P577 | publication date | 2018-09-17 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines | |
| P478 | volume | 10 |
Search more.